Epub 2009 Aug 18
In addition to the direct health benefits, lower heath care utilization, and higher productivity associated with weight loss, other potential benefits of GLP-1 agonists on society include lower spending or demand for groceries and food
In the STEP 1 clinical trial (NEJM, 2021), participants on semaglutide 2.4 mg lost an average of 14.9% of body weight at 68 weeks (about 33.6 lbs from a 232 lb average baseline) vs 2.4% with placebo
At Orthobiologics Associates, we combine weight loss injections with other therapies like peptide therapy, PRP therapy, and integrative medicine
This lower dosing option was recently introduced to help reduce gastrointestinal side effects while maintaining efficacy and enabling smoother escalation than the original dosing strategy
The LVC detects the voltage of the battery, and divides that voltage by the cell count of the battery